Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis

Name: Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis
Published: 2026
License: Public Domain

Inmagene LLC · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

atopicdermatitis dermatitis

atopic dermatitis, atopic dermatitis eczema, eczema, img-007, dermatitis, atopic, dermatitis, skin diseases, immune system diseases, dermatologic agents, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis

Related documents